Neal Hansen is the Managing Director of Hansen Strategy, an independent consulting business focused on advising and facilitating superior decision making in lifecycle management and brand strategy. He has worked with many of the leading pharmaceutical and biotech companies, supporting pipeline, in-line and established brand planning, with a focus on competitive simulations, late stage LCM and emerging markets. Prior to establishing Hansen Strategy, Neal operated as the Global Director of Healthcare Consulting within the Informa Group, leading both Phasic Strategy and Datamonitor Healthcare Consulting. In this role and his previous role as the European Head of Consulting for Wood Mackenzie, he led commercial assessment, scenario planning and war gaming projects for numerous top tier and mid-cap pharmaceutical companies in Europe, the US and Japan.
?
Earlier in his career, he held various senior roles within Datamonitor including Lead Consultant and Lead Analyst for Strategic and Company Intelligence encompassing Strategic Insight, eHealthInsight and PharmaVitae Company Tracking.
Neal holds a PhD in Pharmacology and a MA in Natural Sciences, both from the University of Cambridge
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)